针对有吸烟史高危女性的腹主动脉瘤靶向筛查
这项基于人群的横断面研究在瑞典达拉纳县邀请所有70岁女性(n=9061)参加一次性超声筛查,并鼓励吸烟≥20年者参加,比较靶向筛查与既往一般人群筛查的效果。靶向筛查参与率为42.6%,检出AAA患病率0.8%,高于一般筛查的0.4%,且需筛查人数减半,总人群检出率相似。
要点
- 靶向筛查有吸烟史女性使AAA检出率翻倍(0.8% vs 0.4%)。
- 靶向策略减少约一半需筛查的女性人数。
- 总人群(含未参加者)AAA检出率两种策略相似(0.3% vs 0.2%)。
核心结论
- 对有长期吸烟史的高危女性进行靶向AAA筛查,患病率是一般筛查的两倍(0.8%),且需要筛查的女性人数减半,同时维持检出率。
研究设计与样本
- 基于人群的横断面研究,2018-2022年邀请瑞典达拉纳县所有70岁女性(n=9061)参加一次性主动脉超声筛查,鼓励吸烟≥20年者参加,无排除标准。
- 结果与邻近的达拉纳和乌普萨拉县既往70岁女性一般人群筛查研究进行比较。
主要发现
- 靶向筛查参与率为42.6%(95%CI 41.5%-43.6%),一般筛查为74.2%(95%CI 73.2%-75.2%),P<.001。
- 靶向筛查队列中71%报告吸烟史,一般筛查队列为44%,P<.001。
- 靶向筛查检出AAA患病率为0.8%(95%CI 0.6%-1.1%),一般筛查为0.4%(95%CI 0.2%-0.6%),P<.001。
- 靶向筛查亚动脉瘤(25-29mm)患病率为1.1%(95%CI 0.8%-1.5%),一般筛查为0.6%(95%CI 0.4%-0.8%),P=.0039。
- 总人群(参加者和未参加者)筛查检出AAA:靶向筛查0.3%(95%CI 0.2%-0.5%),一般筛查0.2%(95%CI 0.2%-0.4%),P=.23。
关键数值与推荐
- AAA定义为主动脉直径≥30mm,亚动脉瘤定义为25-29mm。
- 靶向筛查邀请所有70岁女性,鼓励吸烟≥20年者参加,无排除标准。
临床怎么用
- 对有长期吸烟史的70岁女性可采用靶向AAA超声筛查策略,以提高检出效率并减少筛查人数。
局限性
- 需进一步研究评估该方法的临床影响和成本效益。
- 靶向筛查参与率(42.6%)显著低于一般筛查(74.2%),可能影响实际效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: General population-based screening of women for AAA is not recommended. A selective screening approach, targeting high-risk women with a history of smoking, may detect most AAAs and be effective. The aim of this population-based cross-sectional study was to evaluate a pragmatic screening strategy selectively targeting women with a history of smoking. METHODS: Between 2018 and 2022, all 70 year-old women in a defined catchment area, the county of Dalarna in central Sweden, were invited by letter to a one-time ultrasound examination of the aorta. The letter of invitation encouraged women with a smoking history of 20 years or more to attend. No women were excluded. The prevalence of AAA (≥30 mm), sub-AAA (25-29 mm), self-reported comorbidity, and smoking habits were recorded. The results were compared with the outcome from a previous general population-based screening program study of 70-year-old women conducted in the neighboring counties of Dalarna and Uppsala in central Sweden. RESULTS: A total of 9061 women were invited to selective screening; 42.6% (95% confidence interval [CI], 41.5%-43.6%) attended after the invitation to the selective strategy vs 74.2% (95% CI, 73.2%-75.2%) in the previous general screening study (P < .001). In the selective screening cohort, 71% reported a history of smoking vs 44% in the general screening cohort (P < .001). The prevalence of screening-detected AAA was 0.8% (95% CI, 0.6%-1.1%) in the selective screening cohort vs 0.4% (95% CI, 0.2%-0.6%) in the general screening cohort (P < .001) and the corresponding prevalence of subaneurysm was 1.1% (95% CI, 0.8%-1.5%) vs 0.6% (95% CI, 0.4%-0.8%; P = .0039). Screening-detected AAAs in the total population (attenders and nonattenders) were similar between strategies: 0.3% (95% CI, 0.2%-0.5%) for targeted screening vs 0.2% (95% CI 0.2%-0.4%) for general screening (P = .23). CONCLUSIONS: Targeted AAA screening of high-risk women with a long-term smoking history doubles prevalence (0.8%) compared with general screening, halves the number of women needing screening, and maintains the detection rate. Further studies should assess the clinical impact and cost effectiveness of this approach.
引用
- Söderberg P, Wanhainen A, Svensjö S, et al. Targeted screening for abdominal aortic aneurysm in high-risk women with a smoking history. J Vasc Surg. 2026. PMID: 41780650. doi:10.1016/j.jvs.2026.01.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。